Latest News

How to beat COVID-19
It was not on purpose, but Dane County did a good experiment that shows how simple public health measures...
Read more
A new weapon against SARS-CoV-2
Holy COVID inhibition Batman. Hung et. al may have found a powerful weapon against SARS-CoV-2. A study...
Read more
Interferon beta
News of a clinical trial out of the UK shows that interferon β may be the first promising treatment...
Read more
Moderna's mRNA vaccine passes important first hurdle.
Many of you probably already heard that the Moderna vaccine raised a strong immune response in all participants...
Read more
Taking care of a family member, caregiving, does not impact your health
In the U.S. it is estimated that at least 17 million people care for loved ones with significant health...
Read more

Figure 16.2. B cell activation. Binding of antibody activates tyrosine kinase and tyrosine phosphorylase in the cytoplasm that then phosphorylates and dephosphorylates tyrosine residues on the Ig-α/Ig-β polypeptide. These phosphorylation/dephosphorylation reactions activate B cells by at least three different pathways: (i) Activated tyrosine residues on the Ig-α/Ig-β polypeptide cause phospholipase C activity to increase. Phospholipase C then cleaves phospholipids into inositol triphosphate and diacyl glycerol. Diacyl glycerol activates protein kinase C eventually leading to the formation of nuclear factor NF-κB. (ii) Inositol triphosphate causes Ca2+ influx from the endoplasmic reticulum and the outside environment. Increased Ca2+ concentrations activate calmodulin that in turn phosphorylates Ets-1, a DNA binding protein. (iii) Activated tyrosine residues on the Ig-α/Ig-β polypeptide activate the p21ras protein, which leads to the activation of a serine/threonine kinase. This in turn phosphorylates cJUN, another DNA binding protein. NF-κB, Ets-1 and cJUN then travel to the nucleus and cause the transcription of specific genes important in B cell activation.